GENERA DOO has a total of 12 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, measurement and medical technology are GUANGZHOU BAIYUNSHAN QIXING PHARMACEUTICAL CO LTD, HKBU INSTITUTE OF RES AND CONTINUING EDUCATION and HUNAN JIUDIAN PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Medical technology | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Peptides | |
#5 | Object sterilising | |
#6 | Microorganisms | |
#7 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Vukicevic Slobodan | 12 |
#2 | Grgurevic Lovorka | 5 |
#3 | Simic Petra | 4 |
#4 | Macek Boris | 3 |
#5 | Oppermann Hermann | 2 |
#6 | Jelic Mislav | 2 |
#7 | Lowik Clemens W G M | 1 |
#8 | Cecchini Marco G | 1 |
#9 | Van Der Pluijm Gabriel | 1 |
Publication | Filing date | Title |
---|---|---|
CA2658582A1 | Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders | |
CA2657819A1 | Whole blood-derived coagulum device for treating bone defects | |
CA2568305A1 | Insulin-independent, bone morphogenetic protein (bmp)-mediated uptake of blood glucose by peripheral cells and tissues | |
WO2005030933A2 | Bone morphogenetic protein (bmp)-7 based diagnosis and treatment of cancer |